Correspondence 0001640334-23-000762 from Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362) (LEXX)
Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362)
Date: May 4, 2023 · CIK: 0001348362 · Accession: 0001640334-23-000762
AI Filing Summary & Sentiment
File numbers found in text: 333-271096
Letter
Re:
lxrp_corresp.htm
May 4, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Lexaria Bioscience Corp.
Registration Statement on Form S-1, as amended
File No. 333-271096
Ladies and Gentlemen:
As the underwriter of the proposed offering of Lexaria Biosciences. (the “Company”), we hereby withdraw our prior letter to join the acceleration request of the Company dated May 3, 2023 for the above-referenced Registration Statement.
Very truly yours,
Maxim Group LLC
Show Raw Text
CORRESP
1
filename1.htm
lxrp_corresp.htm
May 4, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Re:
Lexaria Bioscience Corp.
Registration Statement on Form S-1, as amended
File No. 333-271096
Ladies and Gentlemen:
As the underwriter of the proposed offering of Lexaria Biosciences. (the “Company”), we hereby withdraw our prior letter to join the acceleration request of the Company dated May 3, 2023 for the above-referenced Registration Statement.
Very truly yours,
Maxim Group LLC
By:
/s/ Clifford A. Teller
Name: Clifford A. Teller
Title: Co-President